Tag Archive for: opko
![](https://stguse2prdmstpublic.blob.core.windows.net/cdn-genpathdiagnostics-com/2021/12/FB-GENPATH-495x400.jpg)
OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test
NewsMIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have…
![](https://stguse2prdmstpublic.blob.core.windows.net/cdn-genpathdiagnostics-com/2020/09/OnkoSight-Image-Tile-495x400.jpg)
OPKO Health’s BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
News, OncologyELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing…